Seqens offers complete and fully integrated R&D services to support your project from initial stage to commercial manufacturing in total compliance with the highest quality, safety and environmental standards.

complete and fully integrated R&D services

Seqens has a balanced portfolio of Big Pharma, mid-sized, specialty pharmaceutical and emerging pharmaceutical companies in the United States, Europe and Japan. We have the flexibility to scale up or down to meet the needs of any customer, whether:

  • An emerging pharmaceutical company that wants to develop a small molecule
  • A mid-sized company looking for a reliable partner to commercialize a Phase I or Phase II molecule and bring it to market or sell it to a Big Pharma company
  • A large pharmaceutical company that needs a partner with multi-site manufacturing capacity for all aspects of API development through Phase I, Phase II and Phase III, and the organizational capability for strong project management to ensure coordinated timelines and protocols and consistent quality

Seqens gives you the best of both worlds—a small, dedicated team, along with the support of a large corporation. The key to your success is our commitment to deliver best-in-class quality-by-design (QbD) methodologies, analytical evaluation, characterization and regulatory services.

Strong R&D capabilities to develop distinctive, cutom-made solutions, to speed up ours clients’ projects by adding value :

  • 3 state-of-the-art R&D center in Europe and the US
  • Our unique range of technologies enables us to manufacture complex molecules for small- and large-scale demands

EXPLORE OUR
R&D services RANGE

DISCOVER PORCHEVILLE 360°TOUR

DISCOVER SEQENS R&D SERVICES OFFER

Our locations

Address 88 Jackson Road, Building 649
MA 01434 Devens
Phone (978) 772 2111
Market Pharmaceutical
Email Accueil@seqens.com
More information

Lab surface: 1, 000 m²

Capabilities:

  • Controlled substances (Schedule II-V)
  • 5 Kilo-Labs

Number of scientists: 30

Address ZI de Limay 2, 8 Rue de Rouen
78440 Porcheville
Phone +33 1 34 79 57 00
Market Pharmaceutical, Specialty Ingredients & Cosmetics
Email ContactSeqensPCV@seqens.com
More information

Surface: 40, 000 m²

Lab surface: 2, 000 m²

Capabilities:

  • 4 kilo-labs
  • 2 cGMP pilot plants with 11 multipurpose reactors from 100 L to 2, 800 L (total capacity of 12 m³)
  • Temperature range: -15/+150°C  (hastelloy reactor: -80/+200°C)
  • 3 finishing rooms (agitated filter dryers, filters, dryers, milling and sieving equipments)

Flagship technologies:

  • Crystallization expertise and technologiesd(salt, co-crystal and polymorph screenings, process development)
  • Process Safety expertise and tecnologies
  • Flow chemistry for fine chemicals
  • Potent API process development
  • Genotoxic Impurities
  • Issue Management
  • Generic A.P.I Solid state expertise

Last inspection: ANSM  October 2018

Certification: GMP

Number of scientists: 110

Other: Ecosystem Pharma with integrated services

Porcheville 360° Tour 
http://www.sweeb.fr/dev/porcheville/Porcheville.html

Address 70 Allée Graham Bell
30000 Nîmes
Phone +33 4 66 70 64 64
Market Pharmaceutical, Specialty Ingredients & Cosmetics
Email seqensrdnimesinfo@seqens.com
More information

Surface: 1, 000 m²

Lab surface: 500 m²

Capacities:

  • 1 kilo-lab in fermentation (80 L total capacity)
  • Robotic platform for highthroughput screening (HTS)
  • Analytical platform for chromatography (GC, GC-MS, U-HPLC)

Flagship technologies: 

  • Protein engineering
  • Microbiology aerobic & anaerobic
  • Syngas fermentation
  • Enzymes & strains fermentation
  • Biochemistry
  • Biocatalysis
  • Design of experiments (DoE)
  • Data mining

Number of scientists: 19